高级检索
当前位置: 首页 > 详情页

Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Beijing Institute of Ophthalmology, TongRen Eye Center, TongRen Hospital, Capital University of Medical Sciences, China [2]Beijing Institute of Ophthalmology and the Beijing TongRen Eye Bank, TongRen Eye Center, Beijing TongRen Hospital, Capital University of Medical Sciences, China [3]Department of Immunology, General Hospital of PLA, China [4]Centre Laboratory, Beijing TongRen Hospital, Capital University of Medical Sciences, China [5]Academy of Military Medical Sciences, China
出处:
ISSN:

摘要:
Aims: To explore the role of staphylococcal enterotoxin B (SEB) in treating high risk corneal keratoplasty in rats. Methods: Rat corneal high risk transplantation rejection models were set up using Fisher 344 and Lewis rats. The experimental rats were injected intraperitoneally with 0.2 ml SEB at different concentrations before keratoplasty. The rejection indexes of the allograft were recorded and the lymphocyte infiltration in the allograft and the percentage of the lymphocyte subpopulation in the lymphatic organs were also examined. Lymphocyte proliferation ability and the concentration of IL-2 and IL-10 in the serum were also evaluated. Results: Compared with the control group, SEB prolonged the survival time of the allograft significantly from 7 to 12 days. It could also reduce CD4(+) and CD8(+) lymphocyte infiltration in the allograft and minimise the percentage of CD4(+) and CD8(+) lymphocytes in the lymphatic organs. The lymphocyte proliferation ability was also weakened. However, the percentage of CD4(+) INK T lymphocytes in the lymphatic organs was raised. The serum concentration of IL-10 was higher but IL-2 was lower in the SEB treated groups. Conclusions: SEB prolonged the survival time of the allograft in high risk rat corneal allo-transplantation, which may be caused by T cell deletion and acquisition of non-specific tolerance.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2004]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 眼科学
JCR分区:
出版当年[2003]版:
Q1 OPHTHALMOLOGY
最新[2023]版:
Q1 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2003版] 出版当年五年平均 出版前一年[2002版] 出版后一年[2004版]

第一作者:
第一作者机构: [1]Beijing Institute of Ophthalmology, TongRen Eye Center, TongRen Hospital, Capital University of Medical Sciences, China
通讯作者:
通讯机构: [2]Beijing Institute of Ophthalmology and the Beijing TongRen Eye Bank, TongRen Eye Center, Beijing TongRen Hospital, Capital University of Medical Sciences, China [*1]Beijing Institute of Ophthalmology and the Beijing TongRen Eye Bank, Beijing TongRen Eye Centre, Beijing TongRen Hospital, Capital University of Medical Sciences, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23475 今日访问量:6 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)